# Antibiotics for Prevention of Infection Following Orthognathic Surgery

> **NCT05852158** · PHASE4 · RECRUITING · sponsor: **Abdul El-Rabbany** · enrollment: 400 (estimated)

## Conditions studied

- Orthognathic Surgical Site Infection

## Interventions

- **DRUG:** Cefazolin 2 GM Injection
- **DRUG:** Cefazolin Injection

## Key facts

- **NCT ID:** NCT05852158
- **Lead sponsor:** Abdul El-Rabbany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-09
- **Primary completion:** 2027-01
- **Final completion:** 2027-07
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05852158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05852158, "Antibiotics for Prevention of Infection Following Orthognathic Surgery". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05852158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*